Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Pharmacogenomics J. Author manuscript; available in PMC 2012 August 1.
Published in final edited form as:
Pharmacogenomics J. 2012 August; 12(4): 297–305.
Published online 2011 March 1. doi: 10.1038/tpj.2011.5

Table 2

Ashkenazi Jewish (AJ) and Sephardi Jewish (SJ) CYP2C19 allele frequencies

AlleleAJ (n =500)
SJ (n =270)
CYP2C19*2–*8 panela
CYP2C19*2–*10, *12–*17, *22 panel
CYP2C19*2–*10, *12–*17, *22 panel
Frequency95% CIFrequency95% CIFrequency95% CI

Abbreviations: CI, confidence interval; n, number of alleles; ND, not determined.

aPartial data from Scott et al., 2007.33
bPreviously reported as CYP2C19*4.33
cCYP2C19*17 allele frequency does not include the c.−806C>T polymorphism of the *4B haplotype.